טוען...

Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation Carriers

BACKGROUND: Hormone therapy (HT) is commonly given to women to alleviate the climacteric symptoms associated with menopause. There is concern that this treatment may increase the risk of breast cancer. The potential association of HT and breast cancer risk is of particular interest to women who carr...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Eisen, Andrea, Lubinski, Jan, Gronwald, Jacek, Moller, Pal, Lynch, Henry T., Klijn, Jan, Kim-Sing, Charmaine, Neuhausen, Susan L., Gilbert, Lucy, Ghadirian, Parviz, Manoukian, Siranoush, Rennert, Gad, Friedman, Eitan, Isaacs, Claudine, Rosen, Eliot, Rosen, Barry, Daly, Mary, Sun, Ping, Narod, Steven A.
פורמט: Artigo
שפה:Inglês
יצא לאור: Oxford University Press 2008
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2556701/
https://ncbi.nlm.nih.gov/pubmed/18812548
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djn313
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!